Formula Systems Reports Record Q2 Earnings, Sells Sapiens to Advent International
ByAinvest
Sunday, Oct 12, 2025 2:15 pm ET1min read
FORTY--
A significant highlight of the quarter was the acquisition of Sapiens International Corporation N.V. (SPNS) by Advent International in an all-cash transaction. Sapiens, a subsidiary specializing in insurance software, was sold for $43.50 per share. This transaction underscores the company's strategy to focus on its core competencies and divest non-core assets to enhance shareholder value.
The acquisition of Sapiens aligns with Formula Systems' broader objective to streamline its operations and concentrate on its core businesses. By divesting Sapiens, the company aims to reduce complexity and improve operational efficiency, allowing it to redirect resources towards its primary technology holdings.
Formula Systems' Q2 performance highlights the company's ability to navigate the dynamic tech market and adapt to changing consumer demands. The record revenues and strategic divestment position the company favorably for future growth prospects. Investors should closely monitor the company's ongoing efforts to unlock value and streamline its operations.
SPNS--
Formula Systems (1985) Ltd. reported record Q2 2025 revenues of $743.4 million, up 11.3% YoY. The Israel-based IT and software holding company is streamlining its holdings and unlocking value across its diverse technology portfolio. The company's insurance-software subsidiary, Sapiens International Corporation N.V., was acquired by Advent International in an all-cash transaction.
Formula Systems (1985) Ltd. (FSL), an Israel-based IT and software holding company, has reported record Q2 2025 revenues of $743.4 million, marking a 11.3% year-over-year (YoY) increase. The company continues to streamline its holdings and unlock value across its diverse technology portfolio, positioning itself for continued growth in the competitive tech landscape.A significant highlight of the quarter was the acquisition of Sapiens International Corporation N.V. (SPNS) by Advent International in an all-cash transaction. Sapiens, a subsidiary specializing in insurance software, was sold for $43.50 per share. This transaction underscores the company's strategy to focus on its core competencies and divest non-core assets to enhance shareholder value.
The acquisition of Sapiens aligns with Formula Systems' broader objective to streamline its operations and concentrate on its core businesses. By divesting Sapiens, the company aims to reduce complexity and improve operational efficiency, allowing it to redirect resources towards its primary technology holdings.
Formula Systems' Q2 performance highlights the company's ability to navigate the dynamic tech market and adapt to changing consumer demands. The record revenues and strategic divestment position the company favorably for future growth prospects. Investors should closely monitor the company's ongoing efforts to unlock value and streamline its operations.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet